DLA
CLB icon

Douglas Lane & Associates’s Core Laboratories CLB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,182
Closed -$413K 247
2023
Q3
$413K Sell
17,182
-41,497
-71% -$996K 0.01% 184
2023
Q2
$1.36M Sell
58,679
-25,453
-30% -$592K 0.02% 142
2023
Q1
$1.86M Sell
84,132
-113,010
-57% -$2.49M 0.03% 137
2022
Q4
$4M Sell
197,142
-360,204
-65% -$7.3M 0.07% 123
2022
Q3
$7.51M Buy
557,346
+6,683
+1% +$90.1K 0.14% 110
2022
Q2
$10.9M Sell
550,663
-37,311
-6% -$739K 0.19% 108
2022
Q1
$18.6M Buy
587,974
+13,830
+2% +$437K 0.26% 98
2021
Q4
$12.8M Sell
574,144
-8,078
-1% -$180K 0.17% 107
2021
Q3
$16.2M Sell
582,222
-10,733
-2% -$298K 0.23% 104
2021
Q2
$23.1M Sell
592,955
-23,315
-4% -$908K 0.32% 91
2021
Q1
$17.7M Sell
616,270
-51,052
-8% -$1.47M 0.28% 94
2020
Q4
$17.7M Buy
667,322
+139,732
+26% +$3.7M 0.3% 92
2020
Q3
$8.05M Buy
527,590
+103,915
+25% +$1.59M 0.16% 105
2020
Q2
$8.61M Buy
423,675
+46,110
+12% +$937K 0.18% 101
2020
Q1
$3.9M Buy
377,565
+107,012
+40% +$1.11M 0.1% 103
2019
Q4
$10.2M Buy
270,553
+100,081
+59% +$3.77M 0.19% 98
2019
Q3
$7.95M Buy
170,472
+76,208
+81% +$3.55M 0.16% 106
2019
Q2
$4.93M Buy
94,264
+26,123
+38% +$1.37M 0.1% 110
2019
Q1
$4.7M Buy
68,141
+10,139
+17% +$699K 0.1% 111
2018
Q4
$3.46M Buy
58,002
+29,440
+103% +$1.76M 0.08% 110
2018
Q3
$3.31M Buy
28,562
+7,197
+34% +$834K 0.07% 118
2018
Q2
$2.7M Buy
21,365
+14,655
+218% +$1.85M 0.06% 122
2018
Q1
$726K Buy
6,710
+4,425
+194% +$479K 0.02% 152
2017
Q4
$250K Sell
2,285
-4,610
-67% -$504K 0.01% 188
2017
Q3
$681K Sell
6,895
-23,339
-77% -$2.31M 0.02% 159
2017
Q2
$3.06M Sell
30,234
-16,358
-35% -$1.66M 0.07% 124
2017
Q1
$5.38M Sell
46,592
-727
-2% -$84K 0.13% 114
2016
Q4
$5.68M Sell
47,319
-4,467
-9% -$536K 0.14% 112
2016
Q3
$5.82M Sell
51,786
-2,459
-5% -$276K 0.16% 110
2016
Q2
$6.72M Sell
54,245
-1,570
-3% -$194K 0.19% 112
2016
Q1
$6.27M Buy
+55,815
New +$6.27M 0.17% 117